RESÚMENES NOVIEMBRE 2007

.

Other Neuropsychiatric Disorders & General Information

(Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

 

3! - Decision-Making Dysfunctions in Psychiatry—Altered Homeostatic Processing?

Martin P. Paulus

Science 26 October 2007: Vol. 318. no. 5850, pp. 602 - 606

5 - Aripiprazole for the Treatment of Psychoses in Institutionalized Patients With Alzheimer Dementia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Assessment of Three Fixed Doses

Jacobo E. Mintzer, Larry E. Tune, Christopher D. Breder, René Swanink, Ronald N. Marcus, Robert D. McQuade, and Andy Forbes

Am J Geriatr Psychiatry 15:918-931, November 2007

5 - Cost-Benefit Analysis of Second-Generation Antipsychotics and Placebo in a Randomized Trial of the Treatment of Psychosis and Aggression in Alzheimer Disease

Robert A. Rosenheck, Douglas L. Leslie, Jody L. Sindelar, Edward A. Miller, Peter N. Tariot, Karen S. Dagerman, Sonia M. Davis, Barry D. Lebowitz, Peter Rabins, John K. Hsiao, Jeffery A. Lieberman, Lon S. Schneider, for the Clinical Antipsychotic Trial of Intervention Effectiveness–Alzheimer's Disease (CATIE-AD) investigators

Arch Gen Psychiatry. 2007;64(11):1259-1268

 

3 - Effects of Sleep Medications on Cognition, Psychomotor Skills, Memory and Driving Performance in the Elderly

Verster, Joris C; Volkerts, Edmund R; Spence, DW; Alford, Chris; Pandi-Perumal, Seithikurippu R

Current Psychiatry Reviews, Volume 3, Number 4, November 2007 , pp. 281-292(12)

 

4 - Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty

Louis J. Mini, Sherry Wang-Weigand and Jeff Zhang

The American Journal of Geriatric Pharmacotherapy. Volume 5, Issue 3, September 2007, Pages 177-184

 

3! - Relation of cognitive activity to risk of developing Alzheimer disease

R. S. Wilson, P. A. Scherr, J. A. Schneider, Y. Tang, and D. A. Bennett

NEUROLOGY 2007;69:1911-1920

3! - Dietary patterns and risk of dementia. The Three-City cohort study

P. Barberger-Gateau, C. Raffaitin, L. Letenneur, C. Berr, C. Tzourio, J. F. Dartigues, and A. Alpérovitch

NEUROLOGY 2007;69:1921-1930

3 - A Randomized Trial of Beta Carotene Supplementation and Cognitive Function in Men. The Physicians' Health Study II

Francine Grodstein, Jae H. Kang, Robert J. Glynn, Nancy R. Cook, J. Michael Gaziano

Arch Intern Med. 2007;167(20):2184-2190

 

3 - A rivastigmine patch for the treatment of Alzheimer’s disease and Parkinson’s disease dementia

Jeffrey Cummings and Bengt Winblad

Expert Review of Neurotherapeutics. November 2007, Vol. 7, No. 11, Pages 1457-1463

 

3 - Distinguishing Lewy body dementias from Alzheimer’s disease

Rawan Tarawneh and James E Galvin

Expert Review of Neurotherapeutics. November 2007, Vol. 7, No. 11, Pages 1499-1516

 

3 - GSK-3 inhibitors for Alzheimer’s disease

Jesús Avila and Félix Hernández

Expert Review of Neurotherapeutics. November 2007, Vol. 7, No. 11, Pages 1527-1533

 

3 - Immunotherapy as treatment for Alzheimer’s disease

Cheryl A Hawkes and JoAnne McLaurin

Expert Review of Neurotherapeutics. November 2007, Vol. 7, No. 11, Pages 1535-1548

 

3 - WHI and WHIMS follow-up and human studies of soy isoflavones on cognition

Liqin Zhao and Roberta Diaz Brinton

Expert Review of Neurotherapeutics. November 2007, Vol. 7, No. 11, Pages 1549-1564

 

3 - Therapies for narcolepsy with or without cataplexy: evidence-based review.

Degenerative and cognitive diseases

Keam, Susan; Walker, Matthew C

Current Opinion in Neurology. 20(6):699-703, December 2007

3 - Neurocognitive Costs and Benefits of Psychotropic Medications in Older Adults

John O. Brooks, Jennifer C. Hoblyn

Journal of Geriatric Psychiatry and Neurology, Vol. 20, No. 4, 199-214 (2007)

5< - Effect of Single-Dose Sertraline on the Hypothalamus-Pituitary-Adrenal System, Autonomic Nervous System, and Platelet Function

Ahrens, Thorben; Frankhauser, Pascal; Lederbogen, Florian; Deuschle, Michael

Journal of Clinical Psychopharmacology. 27(6):602-606, December 2007

3 - 12-Month Follow-Up Study of Drug Treatment in Pathological Gamblers: A Primary Outcome Study

Dannon, Pinhas N; Lowengrub, Katherine; Musin, Ernest; Gonopolsky, Yehudit; Kotler, Moshe

Journal of Clinical Psychopharmacology. 27(6):620-624, December 2007

3! - Association between broadly defined bulimia nervosa and drug use disorders: Common genetic and environmental influences

Jessica H. Baker, Suzanne E. Mazzeo, Kenneth S. Kendler,

International Journal of Eating Disorders. Volume 40, Issue 8, Pages 673 - 678

 

3 - A comparison of early family life events amongst monozygotic twin women with lifetime anorexia nervosa, bulimia nervosa, or major depression

Tracey D Wade, Nathan Gillespie, Nicholas G Martin

International Journal of Eating Disorders. Volume 40, Issue 8, Pages 679 - 686

 

2! - Baclofen for binge eating: An open-label trial

Allegra I. Broft, Alexia Spanos, Rebecca L. Corwin, Laurel Mayer, Joanna Steinglass, Michael J. Devlin, Evelyn Attia, B. Timothy Walsh

International Journal of Eating Disorders. Volume 40, Issue 8, Pages 687 - 691

 

5 - Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

Robin Christensen, Pernelle Kruse Kristensen, Else Marie Bartels, Henning Bliddal and Arne Astrup

The Lancet. Volume 370, Issue 9600, 17 November 2007-23 November 2007, Pages 1706-1713

 

3< - Associations between Use of Benzodiazepines or Related Drugs and Health, Physical Abilities and Cognitive Function: A Non-Randomised Clinical Study in the Elderly

Puustinen, Juha; Nurminen, Janne; Kukola, Matti; Vahlberg, Tero; Laine, Kari; Kivela, Sirkka-Liisa
Drugs & Aging. 24(12):1045-1059, 2007

3 - The effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent?

E. J. M. Bierman, H. C. Comijs, C. M. Gundy, C. Sonnenberg, C. Jonker, A. T. F. Beekman

International Journal of Geriatric Psychiatry.Volume 22, Issue 12, Pages 1194 - 1200

 

3 - Role of the Melatonin System in the Control of Sleep: Therapeutic Implications

Pandi-Perumal, Seithikurippu R; Srinivasan, Venkatramanujan; Spence, D Warren; Cardinali, Daniel

CNS Drugs. 21(12):995-1018, 2007

3< - The impact of psychotropic weight gain on people with psychosis - patient perspectives and attitudes

Marlene S. P. Tham;  Simon G. Jones;  James A. Chamberlain; David J. Castle

Journal of Mental Health, Volume 16, Issue 6 December 2007, pages 771 - 779

 

3! - Polypharmacy in Pregnant Women with Major Psychiatric Illness: A Pilot Study

PEINDL, KATHLEEN S; MASAND, PRAKASH; MANNELLI, PAOLO; NARASIMHAN, MEERA; PATKAR, ASHWIN

Journal of Psychiatric Practice. 13(6):385-392, November 2007

3 - Sex, Depression, and Risk of Hospitalization and Mortality in Chronic Obstructive Pulmonary Disease

Vincent S. Fan, Scott D. Ramsey, Nicholas D. Giardino, Barry J. Make, Charles F. Emery, Phillip T. Diaz, Joshua O. Benditt, Zab Mosenifar, Robert McKenna Jr, Jeffrey L. Curtis, Alfred P. Fishman, Fernando J. Martinez, for the National Emphysema Treatment Trial (NETT) Research Group

Arch Intern Med. 2007;167(21):2345-2353

 

3 - Are Treatments for Common Mental Disorders Also Effective for Functional Symptoms and Disorder?

Richard Mayou

Psychosomatic Medicine 69:876-880 (2007)

3< - Efficacy of Treatment for Somatoform Disorders: A Review of Randomized Controlled Trials

Kurt Kroenke

Psychosomatic Medicine 69:881-888 (2007)

3! - High ω-6 and Low ω -3 Fatty Acids are Associated With Depressive Symptoms and Neuroticism

Sarah M. Conklin, Stephen B. Manuck, Jeffrey K. Yao, Janine D. Flory, Joseph R. Hibbeln, and Matthew F. Muldoon

Psychosomatic Medicine 69:932-934 (2007)

5! - Cholinesterase inhibitors in mild cognitive impairment: A systematic review of randomised trials

Raschetti R, Albanese E, Vanacore N, Maggini M

PLoS Med 4(11): e338

TEXTO GRATUITO

 

3 - Dissociative symptoms are positively related to stress in borderline personality disorder
C. E. Stiglmayr, U. W. Ebner-Priemer, J. Bretz, R. Behm, M. Mohse, C.-H. Lammers, I.-G. Anghelescu, C. Schmahl, W. Schlotz, N. Kleindienst, M. Bohus
Acta Psychiatrica Scandinavica (OnlineEarly Articles). Nov 2007

3 - An update on the pharmacology of galantamine

Mercedes Villarroya, Antonio G García, José Marco-Contelles & Manuela G López

Expert Opinion on Investigational Drugs. December 2007, Vol. 16, No. 12, Pages 1987-1998

 

3! - Routine Laboratory Screening Among Newly Admitted Psychiatric Patients: Is It Worthwhile?

Rosario Arce-Cordon, Maria M. Perez-Rodriguez, Enrique Baca-Baldomero, Ph.D., Maria A. Oquendo, and Enrique Baca-Garcia

Psychiatr Serv 58:1602-1605, December 2007

5 - Assessment of Pharmacokinetics and Pharmacodynamic Effects Related to Abuse Potential of a Unique Oral Osmotic-Controlled Extended-Release Methylphenidate Formulation in Humans

Dolly A. Parasrampuria, Kerri A. Schoedel, Reinhard Schuller, Joan Gu, Patrick Ciccone, Steven A. Silber, and Edward M. Sellers

J Clin Pharmacol Dec 2007

.

Regresar a RESÚMENES NOVIEMBRE 2007